RUBIC (ReproUnion Biobank and Infertility Cohort): A binational clinical foundation to study risk factors, life course, and treatment of infertility and infertility-related morbidity.


Journal

Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129

Informations de publication

Date de publication:
11 2021
Historique:
revised: 03 06 2021
received: 03 05 2021
accepted: 03 06 2021
pubmed: 12 6 2021
medline: 3 3 2022
entrez: 11 6 2021
Statut: ppublish

Résumé

Infertility affects 15%-25% of all couples during their reproductive life span. It is a significant societal and public health problem with potential psychological, social, and economic consequences. Furthermore, infertility has been linked to adverse long-term health outcomes. Despite the advanced diagnostic and therapeutic techniques available, approximately 30% of infertile couples do not obtain a live birth after fertility treatment. For these couples, there are no further options to increase their chances of a successful pregnancy and live birth. Three overall questions will be studied: (1) What are the risk factors and natural life courses of infertility, early embryonic loss, and adverse pregnancy outcomes? (2) Can we develop new diagnostic and prognostic biomarkers for fecundity and treatment success? And (3) what are the health characteristics of women and men in infertile couples at the time of fertility treatment and during long-term follow-up? ReproUnion Biobank and Infertility Cohort (RUBIC) is established as an add-on to the routine fertility management at Copenhagen University Hospital Departments in the Capital Region of Denmark and Reproductive Medicine Centre at Skåne University Hospital in Sweden. The aim is to include a total of 5000 couples equally distributed between Denmark and Sweden. The first patients were enrolled in June 2020. All eligible infertile couples are prospectively asked to participate in the project. Participants complete an extensive questionnaire and undergo a physical examination and collection of biospecimens (blood, urine, hair, saliva, rectal swabs, feces, semen, endometrial biopsies, and vaginal swabs). After the cohort is established, the couples will be linked to the Danish and Swedish national registers to obtain information on parental, perinatal, childhood, and adult life histories, including disease and medication history. This will enable us to understand the causes of infertility and identify novel therapeutic options for this important societal problem.

Sections du résumé

BACKGROUND
Infertility affects 15%-25% of all couples during their reproductive life span. It is a significant societal and public health problem with potential psychological, social, and economic consequences. Furthermore, infertility has been linked to adverse long-term health outcomes. Despite the advanced diagnostic and therapeutic techniques available, approximately 30% of infertile couples do not obtain a live birth after fertility treatment. For these couples, there are no further options to increase their chances of a successful pregnancy and live birth.
OBJECTIVES
Three overall questions will be studied: (1) What are the risk factors and natural life courses of infertility, early embryonic loss, and adverse pregnancy outcomes? (2) Can we develop new diagnostic and prognostic biomarkers for fecundity and treatment success? And (3) what are the health characteristics of women and men in infertile couples at the time of fertility treatment and during long-term follow-up?
MATERIAL AND METHODS
ReproUnion Biobank and Infertility Cohort (RUBIC) is established as an add-on to the routine fertility management at Copenhagen University Hospital Departments in the Capital Region of Denmark and Reproductive Medicine Centre at Skåne University Hospital in Sweden. The aim is to include a total of 5000 couples equally distributed between Denmark and Sweden. The first patients were enrolled in June 2020. All eligible infertile couples are prospectively asked to participate in the project. Participants complete an extensive questionnaire and undergo a physical examination and collection of biospecimens (blood, urine, hair, saliva, rectal swabs, feces, semen, endometrial biopsies, and vaginal swabs). After the cohort is established, the couples will be linked to the Danish and Swedish national registers to obtain information on parental, perinatal, childhood, and adult life histories, including disease and medication history. This will enable us to understand the causes of infertility and identify novel therapeutic options for this important societal problem.

Identifiants

pubmed: 34114375
doi: 10.1111/andr.13063
pmc: PMC10015988
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1828-1842

Subventions

Organisme : EU Interreg ÖKS
Organisme : Capital Region of Denmark
Organisme : Region Skåne
Organisme : Ferring Pharmaceuticals

Informations de copyright

© 2021 American Society of Andrology and European Academy of Andrology.

Références

Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Dan Med Bull. 2006 Nov;53(4):390-417
pubmed: 17150146
Hum Reprod. 2017 Feb;32(2):375-382
pubmed: 27979919
Hum Reprod. 2003 Mar;18(3):628-37
pubmed: 12615837
Hum Reprod. 2018 Mar 1;33(3):361-371
pubmed: 29304248
Eur Urol. 2009 Dec;56(6):1025-31
pubmed: 19297076
Dan Med Bull. 1999 Sep;46(4):357-60
pubmed: 10514944
J Clin Epidemiol. 1998 Nov;51(11):1001-11
pubmed: 9817118
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMJ. 2020 Sep 30;371:m3464
pubmed: 32998909
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Acta Oncol. 2009;48(1):27-33
pubmed: 18767000
Hum Reprod. 2019 Nov 1;34(11):2266-2273
pubmed: 31725880
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
Am J Epidemiol. 2018 Sep 1;187(9):1889-1895
pubmed: 29846493
Cells. 2020 Apr 16;9(4):
pubmed: 32316195
PLoS One. 2020 Sep 3;15(9):e0237422
pubmed: 32881896
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
Scand J Public Health. 2011 Jul;39(7 Suppl):42-5
pubmed: 21775350
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Andrology. 2021 Nov;9(6):1828-1842
pubmed: 34114375
Fertil Steril. 2020 Mar;113(3):569-577.e1
pubmed: 32044090
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Fertil Steril. 2018 Jan;109(1):6-19
pubmed: 29307404
Patient Educ Couns. 2005 Dec;59(3):244-51
pubmed: 16310331
Hum Reprod. 2015 Aug;30(8):1952-63
pubmed: 26113657
Hum Reprod. 2015 Feb;30(2):353-63
pubmed: 25480922
J Clin Epidemiol. 1998 Nov;51(11):991-9
pubmed: 9817117
BMJ Open. 2018 Aug 17;8(8):e020293
pubmed: 30121591
Hum Reprod. 2005 Apr;20(4):1044-52
pubmed: 15608029
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
J Affect Disord. 2017 Mar 01;210:338-344
pubmed: 28088111
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Int J Epidemiol. 2019 Oct 1;48(5):1413-1413k
pubmed: 31730707
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
Sociol Health Illn. 2010 Jan;32(1):140-62
pubmed: 20003036
J Sex Res. 2010 Jul;47(4):257-68
pubmed: 19629836
Hum Reprod. 2002 Sep;17(9):2468-73
pubmed: 12202443
Nord J Psychiatry. 2003;57(2):113-8
pubmed: 12745773
Mult Scler. 2018 Dec;24(14):1835-1842
pubmed: 29027840
Fertil Steril. 2016 Mar;105(3):629-636
pubmed: 26674559
Psychol Med. 1985 Feb;15(1):189-94
pubmed: 3991833
Eur J Contracept Reprod Health Care. 2014 Aug;19(4):231-7
pubmed: 24901746
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Eur J Epidemiol. 2016 Feb;31(2):125-36
pubmed: 26769609
Physiol Rev. 2016 Jan;96(1):55-97
pubmed: 26582516
Hum Reprod. 2005 Nov;20(11):3248-56
pubmed: 16006458
Hum Reprod. 2019 Nov 1;34(11):2290-2296
pubmed: 31600391
Am J Epidemiol. 2009 Sep 1;170(5):559-65
pubmed: 19635736
Scand J Work Environ Health. 2015 Sep 1;41(5):486-90
pubmed: 26111225
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
Andrology. 2013 Sep;1(5):741-8
pubmed: 23843214
Hum Reprod. 2017 Jul 1;32(7):1474-1481
pubmed: 28486688
Hum Reprod. 2017 Jul 1;32(7):1439-1449
pubmed: 28472455
Scand J Soc Med. 1990 Jun;18(2):143-8
pubmed: 2367825

Auteurs

Laerke Priskorn (L)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Sandra Søgaard Tøttenborg (SS)

Department of Occupational and Environmental Health, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Kristian Almstrup (K)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Anna-Maria Andersson (AM)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Jonatan Axelsson (J)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.

Elvira Vaclavik Bräuner (EV)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Angel Elenkov (A)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.

Nina la Cour Freiesleben (NC)

The Fertility Clinic, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Yvonne Lundberg Giwercman (YL)

Department of Translational Medicine, Lund University, Malmö, Sweden.

Marie Louise Grøndahl (ML)

Fertility Clinic, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.

Ann Holm Hansen (AH)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Laura Smidt Hansen (LS)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Emir Henic (E)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.

Margareta Laczna Kitlinski (ML)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.

Selma Kloeve Landersoe (SK)

Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Department of Obstetrics and Gynecology, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.

Christian Lindh (C)

Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.

Ellen Leth Løkkegaard (EL)

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Obstetrics and Gynecology, Copenhagen University Hospital - North Zealand, Copenhagen, Denmark.

Johan Malm (J)

Department of Translational Medicine, Lund University, Malmö, Sweden.

Kristina Wendelboe Olsen (KW)

Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Kajsa Uglevig Petersen (KU)

Department of Occupational and Environmental Health, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Lone Schmidt (L)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Sacha Stormlund (S)

Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Pernille Fog Svendsen (PF)

Fertility Clinic, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.

Ditte Vassard (D)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Nathalie Friis Wang (NF)

Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Anne Zedeler (A)

Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Shalender Bhasin (S)

Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Jorge Chavarro (J)

Departments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Michael L Eisenberg (ML)

Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, Stanford, California, USA.

Russ Hauser (R)

Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Ilpo Huhtaniemi (I)

Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.

Stephen A Krawetz (SA)

Department of Obstetrics and Gynecology, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA.

György Marko-Varga (G)

Department of Biomedical Engineering, Lund University, Lund, Sweden.

Andrea Salonia (A)

Graduate School of Urology, University Vita-Salute San Raffaele, Milan, Italy.
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Jorma Toppari (J)

Institute of Biomedicine, Research Centre for Integrated Physiology and Pharmacology, University of Turku, Turku, Finland.
Centre for Population Health Research, University of Turku, Turku, Finland.
Department of Pediatrics, Turku University Hospital, Turku, Finland.

Anders Juul (A)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Niels Jørgensen (N)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Henriette Svarre Nielsen (HS)

The Fertility Clinic, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Anja Pinborg (A)

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Fertility Department, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Lars Rylander (L)

Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.

Aleksander Giwercman (A)

Reproductive Medicine Center, Skåne University Hospital, Malmö, Sweden.
Department of Translational Medicine, Lund University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH